Cargando…
The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress
Genotoxic agents, that are used in cancer therapy, elicit the reprogramming of the transcriptome of cancer cells. These changes reflect the cellular response to stress and underlie some of the mechanisms leading to drug resistance. Here, we profiled genome-wide changes in pre-mRNA splicing induced b...
Autores principales: | Lemaitre, Florence, Chakrama, Fatima, O’Grady, Tina, Peulen, Olivier, Rademaker, Gilles, Deward, Adeline, Chabot, Benoit, Piette, Jacques, Colige, Alain, Lambert, Charles, Dequiedt, Franck, Habraken, Yvette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825188/ https://www.ncbi.nlm.nih.gov/pubmed/36477312 http://dx.doi.org/10.1093/nar/gkac1130 |
Ejemplares similares
-
Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis
por: Gabriel, Maude, et al.
Publicado: (2015) -
The RNA recognition motif protein RBM11 is a novel tissue-specific splicing regulator
por: Pedrotti, Simona, et al.
Publicado: (2012) -
ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion
por: Saulnier, Olivier, et al.
Publicado: (2021) -
Tunable regulation of CREB DNA binding activity couples genotoxic stress response and metabolism
por: Kim, Sang Hwa, et al.
Publicado: (2016) -
Mitochondrial stress induces AREG expression and epigenomic remodeling through c-JUN and YAP-mediated enhancer activation
por: Hino, Yuko, et al.
Publicado: (2022)